AACR START Grant offers industry and academia experience

Clinical research

Postdoctoral and clinical fellows are invited to apply for the AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grant by June 21, 2023.

This three-year, $225,000 grant will provide the opportunity for training and research in both academia and industry, while allowing recipients to spend one year at a Johnson & Johnson facility.

Applicants must be female or belong to one of the underrepresented groups as per the NIH guidelines (Notice of NIH’s Interest in Diversity), and the research proposal must have direct applicability to lung cancer.

The AACR-Lung Cancer Initiative at Johnson & Johnson START Grant represents an opportunity to address the need for promoting and supporting academia-industry collaborations.

It is hoped that the training provided through this initiative will be invaluable to young investigators by providing fellows with a comprehensive research experience that will make them desirable to potential employers in either academic research or the pharmaceutical industry.

Research proposals focused on mechanisms linking immunogenic cell death pathways to amplification of innate and adaptive immunity, immunobiology of non-small cell lung cancers, and mechanisms of acquired resistance to immunotherapies are highly encouraged.

Find out more details and how to apply.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free